特朗普推出折扣处方药网站TrumpRx，作为降低美国药价的核心举措

Core Viewpoint - The launch of TrumpRx.gov aims to provide consumers with discounted prescription drugs as part of the effort to lower drug prices in the U.S. [1][3] Group 1: Platform Details - TrumpRx.gov is designed primarily for consumers who purchase medications without insurance, meaning most drug costs will not count towards patients' insurance deductibles [2][4] - The platform will be supported by GoodRx, a prescription drug savings platform, and will not sell drugs directly but will guide patients to other sites for purchases [1][3] Group 2: Agreements with Pharmaceutical Companies - Sixteen major pharmaceutical companies have entered into "most favored nation" agreements with the Trump administration, committing to lower drug prices in exchange for tariff exemptions [1][3] - Companies involved in these agreements include Eli Lilly, Novo Nordisk, Pfizer, AstraZeneca, Merck, and GlaxoSmithKline [5] Group 3: Expected Cost Reductions - The government anticipates that the initiative will reduce the average monthly medication costs for Americans to a range of $149 to $350 [1][3] - Eli Lilly and Novo Nordisk have agreed to price reductions for popular GLP-1 weight loss drugs, which currently account for over 10% of their total sales [1][3]